Anti-CAR Immunity Drives Acquired Therapeutic Resistance to GD2-CAR T Cell Therapy in Diffuse Midline Glioma. - Chen Y; Reynolds K; Koch MRA; Petrakian CF; Good Z; Yamada-Hunter S; Sotillo E; Song KW; Mahdi J; Majzner R; Desai MH; Huang YW; et al. (MedRxiv : the preprint server for health sciences, 2026)